Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Feb 27, 2024; 16(2): 382-395
Published online Feb 27, 2024. doi: 10.4240/wjgs.v16.i2.382
Table 3 Univariate and multivariate Cox regression analyses for overall survival in patients with robotic gastrectomy
Variables

Univariate analysis
Multivariate analysis
HR95%CI valueP valueHR95%CIP value
Gender Male/female0.7430.400-1.3790.346
Age (yr)1.051.023-1.077< 0.0011.0671.035-1.099< 0.001
Underlying diseaseNo/yes1.3070.759-2.2480.334
BMI0.980.915-1.0480.553
Tumor location0.264
Upper third Ref
Middle third 0.4340.117-1.6040.211
Lower third1.130.379-2.2740.733
Tumor dimensions (cm)< 3/≥ 30.4940.266-0.9170.0250.6720.338-1.3380.258
DifferentiationModerate and poor/well0.0470.000-11.3420.275
TNM stage0.0050.025
IRefRef
II3.771.264-8.7090.0423.031.243-7.9840.047
III5.6952.181-9.8450.0015.682.161-9.5410.01
OperationSubtotal gastrectomy /total gastrectomy1.4230.893-2.2690.138
ASAI-II/III-IV1.1180.535-2.3360.767
Perioperative transfusionNo/yes1.580.959-2.6030.073
Blood loss (mL)> 200 mL/≤ 200 mL1.7631.109-2.8030.0161.4980.914-2.4580.109
Operation time (minutes)1.0010.997-1.0040.938
CA199 (ng/mL)Negative/positive1.3470.780-2.3270.286
CEA (ng/mL)Negative/positive2.4731.543-3.963< 0.0011.2660.76-2.1080.365
Postoperative complicationNo/yes4.7872.846-8.052< 0.0017.2443.780-13.781< 0.001
Postoperative chemotherapyNo/yes2.9291.543-5.5620.0011.2980.649-2.5970.461
P53Wild/Mutant0.7280.455-1.1650.1860.3920.231-0.663< 0.001
Ki-670.1370.003
0%-49%RefRef
50%-74%1.1370.471-2.7430.7752.0880.822-5.3030.121
75%-100%0.7020.297-1.6610.4210.7880.321-1.9320.603
Her-2Negative/positive0.3210.079-1.3100.113
Lymph node metastasis rate (%)< 4.6%/≥ 4.6%5.9432.845-12.414< 0.0012.2660.897-5.7240.083
Enteral nutrition time1.0230.965-1.1860.443
Length of hospitalization (days)1.0320.995-1.0700.092
SIRI≤ 1.38/> 1.383.7872.376-6.034< 0.0012.6961.579-4.404< 0.001